Antimetabolites

DROXIA 6337 DROXIA 6337 Pill - orange capsule-shape, 22mm

Generic Name: hydroxyurea

Pill with imprint DROXIA 6337 DROXIA 6337 is Orange, Capsule-shape and has been identified as Droxia 400 mg. It is supplied by Bristol-Myers Squibb.

Droxia is used in the treatment of Anemia, Sickle Cell; Solid Tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Droxia (Hydroxyurea [ hye-drox-ee-yoo-ree-a ])-DROXIA 6337 DROXIA 6337-400 mg-Orange-Capsule-shape
Droxia (Hydroxyurea [ hye-drox-ee-yoo-ree-a ])-DROXIA 6337 DROXIA 6337-400 mg-Orange-Capsule-shape
Droxia (Hydroxyurea [ hye-drox-ee-yoo-ree-a ])-DROXIA 6337 DROXIA 6337-400 mg-Orange-Capsule-shape

Droxia
Generic Name: hydroxyurea [ hye-drox-ee-yoo-ree-a ]
Imprint: DROXIA 6337 DROXIA 6337
Strength: 400 mg
Color: Orange
Size: 22.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Antimetabolites
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00003-6337
Inactive Ingredients: Citric acid monohydrate, Gelatin, Magnesium stearate, Sodium phosphate, Titanium dioxide, D&C Red No. 28, D&C Red No. 33, D&C Yellow No. 10,
Latest News
Related Drugs